Jacobs Levy Equity Management
NARI

Jacobs Levy Equity Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Jacobs Levy Equity Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-118,576
Closed -$6.05M – 1229
2024
Q4 		$6.05M Sell
118,576
-4,146
-3% -$204K 0.02% 394
2024
Q3 		$5.06M Sell
122,722
-103,421
-46% -$4.97M 0.02% 442
2024
Q2 		$10.9M Sell
226,143
-32,077
-12% -$1.42M 0.05% 321
2024
Q1 		$12.4M Buy
258,220
+298
+0.1% +$15.9K 0.06% 268
2023
Q4 		$16.7M Buy
+257,922
New +$15.5M 0.08% 230
2023
Q3 		– Sell
-131,913
Closed -$7.67M – 1082
2023
Q2 		$7.67M Buy
+131,913
New +$8.32M 0.04% 315

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $426M AUM 23.62% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Jacobs Levy Equity Management's NARI Position: Q1 2025 in Review

Jacobs Levy Equity Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 118,576 shares — an estimated $6.05M sold.

Jacobs Levy Equity Management first reported a position in NARI in Q2 2023 and held it in 6 quarters. The position peaked at $16.7M in Q4 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Jacobs Levy Equity Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 118,576 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $6.05M.
  • Jacobs Levy Equity Management first reported a position in Inari Medical, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
  • Jacobs Levy Equity Management's Inari Medical, Inc. Common Stock position peaked at $16.7M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2025, filed 15 May 2025.